New Report “Market Access Brazil: Unlocking Pharma Potential” Now Available at MarketPublishers.com
05 Sep 2011 • by Natalie Aster
LONDON – Brazil is a rapidly expanding economy with a whole row of new project launches and a definite willingness to encourage a wide stream of investments into the country, pharmaceutical industry being part of the investment programme. However there are concers and challenges surrounding this path. Complex tax laws, pricing procedures, slow product approvals and linguistic barriers hinder the development of the pharmaceutical market. has indicated a willingness to encourage long-term foreign investment in the pharmaceutical industry. Moreover government-favoured generics and low-priced illegally-traded drugs (25% of the total supply on the pharmaceutical market in Brazil) are impeding the presence endeavors and pose critical competition.
New market research report “Market Access Brazil: Unlocking Pharma Potential” worked out by FirstWord offers an in-depth examination of health care and pharmaceutical industry in Brazil. It addresses critical issues such as responsibilities and the role of the National Health Surveillance Agency to consumer trends, the latest patent protection issues, the role of generics and ongoing battle over intellectual property. Covering interviews with experts, financial comparatives and updates from multinationals in the region, the report presents a full-view picture and analysis of Brazil’s pharmaceutical industry.
Report Details:
Title: Market Access Brazil: Unlocking Pharma Potential
Published: July, 2011
Pages: 38
Price: US$ 795
Report Contents:
Executive Summary
Introduction
The Brazilian pharmaceutical market
Healthcare provision
Health sector responsibilities
ANVISA
Principal pharmaceutical patent legislation
Patent protection
Pharmaceutical patent applications (Jan 2001-Jan 2011)
Accessing the Brazilian pharmaceutical market
Trends in the Brazilian pharmaceutical market
Prescription Data for Brazil, 2009/10
Pharmaceuticals in Brazil, User Profile
Pharmaceutical Production in Brazil by Type of Capital, 2010
Intellectual Property
Generics
Estimated Market Shares of the Top 10 Pharma Companies in Brazil, June 2011
Licensing agreements
Measures to ensure the legality of medicines in Brazil
Interview with Marin Osorio, Senior Secretary, Ministry of Health
Price control
New reimbursement legislation
Multiple trade marks
The ’Pipeline Mechanism’
Investing within a protectionist environment
Establishing a presence in Brazil
…
To order the report or ask for free sample pages, please contact [email protected]
CONTACTS
The Market Publishers, Ltd.
Tanya Rezler
Tel: +44 208 144 6009
Fax: +44 207 900 3970